End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.36 MYR | +9.09% | -.--% | +9.09% |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Capitalization 1 | 69.12 | 71.28 | 71.28 | 71.28 | 71.28 |
Enterprise Value (EV) 1 | 77.08 | 75.74 | 79.99 | 85.61 | 76.47 |
P/E ratio | -16.5 x | 8.75 x | 12.4 x | 20.2 x | 8.4 x |
Yield | - | 4.24% | 6.97% | 4.24% | 3.03% |
Capitalization / Revenue | 1.66 x | 1.61 x | 1.56 x | 1.49 x | 1.04 x |
EV / Revenue | 1.85 x | 1.71 x | 1.75 x | 1.79 x | 1.12 x |
EV / EBITDA | -31.3 x | 9.25 x | 8.44 x | 11.4 x | 5.65 x |
EV / FCF | -50.2 x | 27.2 x | 50.3 x | -27.4 x | 7.06 x |
FCF Yield | -1.99% | 3.67% | 1.99% | -3.64% | 14.2% |
Price to Book | 2.02 x | 1.82 x | 1.78 x | 1.76 x | 1.52 x |
Nbr of stocks (in thousands) | 216,000 | 216,000 | 216,000 | 216,000 | 216,000 |
Reference price 2 | 0.3200 | 0.3300 | 0.3300 | 0.3300 | 0.3300 |
Announcement Date | 20-06-30 | 21-04-30 | 22-04-28 | 23-04-28 | 24-03-15 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 61.28 | 41.68 | 44.27 | 45.79 | 47.95 | 68.3 |
EBITDA 1 | 4.366 | -2.46 | 8.192 | 9.476 | 7.485 | 13.54 |
EBIT 1 | 2.817 | -3.581 | 6.956 | 8.278 | 6.153 | 11.86 |
Operating Margin | 4.6% | -8.59% | 15.71% | 18.08% | 12.83% | 17.37% |
Earnings before Tax (EBT) 1 | 4.481 | -2.936 | 10.23 | 7.849 | 5.433 | 11.23 |
Net income 1 | 2.867 | -3.073 | 8.144 | 5.753 | 3.537 | 8.49 |
Net margin | 4.68% | -7.37% | 18.39% | 12.57% | 7.38% | 12.43% |
EPS 2 | 0.4411 | -0.0194 | 0.0377 | 0.0266 | 0.0164 | 0.0393 |
Free Cash Flow 1 | -3.067 | -1.535 | 2.78 | 1.59 | -3.119 | 10.83 |
FCF margin | -5.01% | -3.68% | 6.28% | 3.47% | -6.5% | 15.86% |
FCF Conversion (EBITDA) | - | - | 33.93% | 16.78% | - | 79.97% |
FCF Conversion (Net income) | - | - | 34.13% | 27.64% | - | 127.57% |
Dividend per Share 2 | 0.6154 | - | 0.0140 | 0.0230 | 0.0140 | 0.0100 |
Announcement Date | 19-05-30 | 20-06-30 | 21-04-30 | 22-04-28 | 23-04-28 | 24-03-15 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 14.8 | 7.96 | 4.46 | 8.71 | 14.3 | 5.19 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 3.398 x | -3.236 x | 0.5444 x | 0.9195 x | 1.915 x | 0.3831 x |
Free Cash Flow 1 | -3.07 | -1.54 | 2.78 | 1.59 | -3.12 | 10.8 |
ROE (net income / shareholders' equity) | 9.1% | -9.44% | 22.2% | 14.5% | 8.78% | 19.4% |
ROA (Net income/ Total Assets) | 2.89% | -3.73% | 7.77% | 8.85% | 6.18% | 11% |
Assets 1 | 99.2 | 82.46 | 104.8 | 64.99 | 57.25 | 77.21 |
Book Value Per Share 2 | 4.760 | 0.1600 | 0.1800 | 0.1900 | 0.1900 | 0.2200 |
Cash Flow per Share 2 | 0.3500 | 0.0200 | 0.0300 | 0.0200 | 0.0100 | 0.0200 |
Capex 1 | 3.75 | 0.24 | 0.65 | 2.08 | 1.32 | 0.36 |
Capex / Sales | 6.11% | 0.57% | 1.46% | 4.54% | 2.76% | 0.52% |
Announcement Date | 19-05-30 | 20-06-30 | 21-04-30 | 22-04-28 | 23-04-28 | 24-03-15 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+9.09% | 16.52M | |
+17.66% | 84.57B | |
+19.84% | 24.33B | |
+24.11% | 11.68B | |
+25.50% | 11.21B | |
+2.88% | 7.08B | |
+21.74% | 4.8B | |
+20.15% | 4.63B | |
-7.46% | 2.93B | |
-6.21% | 2.34B |
- Stock Market
- Equities
- FBBHD Stock
- Financials Fibromat (M)